Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Frontiers in Psychiatry|March 5, 2025
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depressionJian-Qiang Tan, Li-Mei Gu, Yan-Ling Zhou, et al.Frontiers in Psychiatry|October 3, 2022
Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depressionWei Zheng, Xin-Hu Yang, Li-Mei Gu, et al.Frontiers in Psychiatry|July 1, 2025
Rapid treatment center for depression in China: constructive reflections and transnational implicationsZhan-Ming Shi, Xing-Bing Huang, Yan-Ling Zhou, et al.Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|March 23, 2023
[Electroencephalogram Features of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Value for Clinical Assessment]Xiao-Ying Pan, Guo-Hua Chen, Yu-Ping Ning, et al.Journal of Affective Disorders|February 16, 2024
NEFA can serve as good biological markers for the diagnosis of depression in adolescentsGuan-Xi Liu, Ze-Lin Li, Su-Yan Lin, et al.Peerj|November 16, 2020
Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary studyWei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, et al.Peerj|April 14, 2021
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depressionWei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, et al.International Journal of Psychiatry in Clinical Practice|October 30, 2022
Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusionsWei Zheng, Li-Mei Gu, Xin-Hu Yang, et al.Neuropsychiatric Disease and Treatment|December 18, 2018
Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinicsWei Zheng, Xin-Ni Luo, Hai-Yan Li, et al.Journal of Psychopharmacology (Oxford, England)|April 5, 2017
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trialsWei Zheng, Xin-Hu Yang, Dong-Bin Cai, et al.Pageof 8